USPTO serial 98626861
TANKA
Reviewed by CopyMark Law Group
Status 653
- Filing date
- Status date
- Registration date
- —
- Examiner
- ROTH, BENJAMIN H.
- Law office
- TMO LAW OFFICE 122
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with TANKA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alexandra Kochian
Alexandra Kochian Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd St., 17th FLNew York, NY 10036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of rare diseases, rare blood disorders, and oncologic, immunologic, and neurologic diseases and disorders; monoclonal and polyclonal antibodies for medical purposes; diagnostic preparations for medical and veterinary use; biological tissue cultures for medical and veterinary use | ACTIVE | — |
| 042 | Scientific research and laboratory research services in the field of biotechnology; biological and pharmaceutical research; biotechnical research; advice being consulting services in the field of biotechnology, bacteriological research, biological research, research and development of new pharmaceutical products and new component products for third parties, medical and scientific research, namely, conducting clinical trials for others; chemical analysis and research services; medical research; pharmaceutical research services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 3, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 3, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 3, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 3, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 3, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 2, 2026 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jun 16, 2026 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jun 16, 2026 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jun 16, 2026 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jun 16, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Dec 16, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Dec 16, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Dec 16, 2025 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Dec 15, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 15, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 15, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 15, 2025 | ALIE | ASSIGNED TO LIE | — |
| Dec 1, 2025 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Sep 9, 2025 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Sep 9, 2025 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Sep 9, 2025 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Sep 6, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jun 30, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jun 30, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 30, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jun 30, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 30, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 5, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 5, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 5, 2025 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 5, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 5, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 5, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 27, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 27, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 27, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 17, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 14, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 1, 2024 | NWAP | NEW APPLICATION ENTERED | — |